SHENYANG, China, May 11 /PRNewswire-Asia/ -- 3SBio Inc.
(Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern).
Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity.
The conference call may be accessed using the dial-in numbers below:
Conference ID: 74760426
Local dial-in:
China - landline 800 819 0121
China - mobile 400 620 8038
Hong Kong - 852 2475 0994
International toll-free dial-in:
Hong Kong 800 930 346
United Kingdom 080 8234 6646
United States 1 866 519 4004
International toll dial-in: 65 6723 9381
A telephone replay will be available two hours after the call until May 24, 2010 at:
International dial-in: +61-2-8235-5000
United States dial-in: 1-866-214-5335
Replay- Conference ID: 74760426
Webcast
A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/3sbio2010Q1 . A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3SBio.com
Investor Contacts
Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: +86-24-2581-1820
Email: ir@3SBio.com
Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: +852-8191-6991
Email: ir@3SBio.com